These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30415456)

  • 21. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
    Hosseinalizadeh H; Mahmoodpour M; Samadani AA; Roudkenar MH
    Med Oncol; 2022 Jun; 39(9):130. PubMed ID: 35716323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.
    Alkonyi B; Mittal S; Zitron I; Chugani DC; Kupsky WJ; Muzik O; Chugani HT; Sood S; Juhász C
    J Neurooncol; 2012 Apr; 107(2):365-72. PubMed ID: 22048879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.
    Juhász C; Nahleh Z; Zitron I; Chugani DC; Janabi MZ; Bandyopadhyay S; Ali-Fehmi R; Mangner TJ; Chakraborty PK; Mittal S; Muzik O
    Nucl Med Biol; 2012 Oct; 39(7):926-32. PubMed ID: 22444239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.
    Ahlstedt J; Konradsson E; Ceberg C; Redebrandt HN
    PLoS One; 2020; 15(5):e0233617. PubMed ID: 32469935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.
    Bosnyák E; Michelhaugh SK; Klinger NV; Kamson DO; Barger GR; Mittal S; Juhász C
    Clin Nucl Med; 2017 May; 42(5):341-347. PubMed ID: 28195901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
    Opitz CA; Litzenburger UM; Opitz U; Sahm F; Ochs K; Lutz C; Wick W; Platten M
    PLoS One; 2011; 6(5):e19823. PubMed ID: 21625531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
    Michelhaugh SK; Muzik O; Guastella AR; Klinger NV; Polin LA; Cai H; Xin Y; Mangner TJ; Zhang S; Juhász C; Mittal S
    J Nucl Med; 2017 Feb; 58(2):208-213. PubMed ID: 27765857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of IDO1 enzyme activity in normal and malignant tissues.
    Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA
    Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Radiosynthesis and Biological Evaluations of L- and D-1-[
    Xin Y; Cai H
    Mol Imaging Biol; 2017 Aug; 19(4):589-598. PubMed ID: 27815661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity.
    Juhász C; Chugani DC; Barger GR; Kupsky WJ; Chakraborty PK; Muzik O; Mittal S
    Clin Nucl Med; 2012 Sep; 37(9):838-42. PubMed ID: 22889771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
    Labadie BW; Bao R; Luke JJ
    Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.
    Kamson DO; Juhász C; Buth A; Kupsky WJ; Barger GR; Chakraborty PK; Muzik O; Mittal S
    J Neurooncol; 2013 Mar; 112(1):121-32. PubMed ID: 23299463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
    Mandarano M; Orecchini E; Bellezza G; Vannucci J; Ludovini V; Baglivo S; Tofanetti FR; Chiari R; Loreti E; Puma F; Sidoni A; Belladonna ML
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial watch: IDO inhibitors in cancer therapy.
    Le Naour J; Galluzzi L; Zitvogel L; Kroemer G; Vacchelli E
    Oncoimmunology; 2020 Jun; 9(1):1777625. PubMed ID: 32934882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy.
    Wu L; Wang D; Chen Y; Qian M; Xu X; Zhang T; Bi N; Wang L
    Front Immunol; 2022; 13():906815. PubMed ID: 36032151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.
    Kamson DO; Mittal S; Robinette NL; Muzik O; Kupsky WJ; Barger GR; Juhász C
    Neuro Oncol; 2014 Oct; 16(10):1373-83. PubMed ID: 24670609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fully automated radiosynthesis of N(1)-[(18)F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging.
    Henrottin J; Lemaire C; Egrise D; Zervosen A; Van den Eynde B; Plenevaux A; Franci X; Goldman S; Luxen A
    Nucl Med Biol; 2016 Jun; 43(6):379-89. PubMed ID: 27260779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma.
    Jacquerie A; Hoeben A; Eekers DBP; Postma AA; Vanmechelen M; de Smet F; Ackermans L; Anten M; Severens K; Zur Hausen A; Broen MPG; Beckervordersandforth J
    Sci Rep; 2024 Jun; 14(1):14975. PubMed ID: 38951170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.